The FDA approved viscosupplementation for osteoarthritis of the knee in 1997. There are several products on the market, one of which is a natural product made from the comb of a rooster.

Compared with placebo, viscosupplementation provided a small reduction in pain but increased risk of serious adverse events in patients with knee osteoarthritis, according to published results ...

Source Reference: Pereira T, et al "Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis" BMJ 2022; DOI: 10.1136/bmj-2022-069722. Share on Facebook. Opens in a new tab ...

DUBLIN--(BUSINESS WIRE)--The "Global Hyaluronic Acid Viscosupplementation Market Size, Share, and COVID-19 Impact Analysis 2023-2029 MedCore - Includes: Single Injection, Two Injections, and 2 ...

DUBLIN--(BUSINESS WIRE)--The "Viscosupplementation Market, Global Forecast Report by Product, By Application, by End User, Regions and Company Analysis 2025-2033" report has been added to ...

A single injection of a new, off-the-shelf stem cell therapy for knee osteoarthritis significantly improved pain and function for up to 12 months in 75% of participants involved in a clinical trial.